World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
12855
World Ranking
3149
National Ranking
1477

Ann M. Leen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ann M. Leen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 288 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ann M. Leen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ann M. Leen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ann M. Leen is affiliated with Baylor College of Medicine in the United States. Their research primarily spans the fields of medicine and immunology and microbiology, with particular focus on subfields including oncology, immunology, epidemiology, infectious diseases, and genetics.

The main topics of their work cover:

  • CAR-T cell therapy research
  • Cytomegalovirus and herpesvirus research
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Hematopoietic Stem Cell Transplantation
  • SARS-CoV-2 and COVID-19 Research

Their recent publications include the following papers:

  • "Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting" (2023), published in Clinical Cancer Research
  • "Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer" (2021), published in Journal for ImmunoTherapy of Cancer
  • "Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant" (2020), published in Blood
  • "LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study" (2024), published in The Lancet Oncology
  • "T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects" (2021), published in Journal of Clinical Oncology

Frequent co-authors who have collaborated with Ann M. Leen include:

  • Spyridoula Vasileiou
  • Manik Kuvalekar
  • Premal Lulla
  • Ayumi Watanabe
  • Helen E. Heslop

The most common venues for their publications are:

  • Blood
  • Transplantation and Cellular Therapy
  • Cytotherapy
  • Journal of Clinical Oncology
  • Blood Advances

Best Publications

  • Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

    Ann M. Leen;G. Doug Myers;Uluhan Sili;M. Helen Huls

  • Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

    Ann M. Leen;Catherine M. Bollard;Adam M. Mendizabal;Elizabeth J. Shpall

  • Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

    Ifigeneia Tzannou;Anastasia Papadopoulou;Swati Naik;Kathryn Leung

  • Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

    Anastasia Papadopoulou;Ulrike Gerdemann;Usha L. Katari;Ifigenia Tzannou

  • Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

    Ann M. Leen;Anne Christin;Gary D. Myers;Hao Liu

  • Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

    Catherine M. Bollard;Stephen Gottschalk;Ann M. Leen;Heidi Weiss

  • Functionally active virus-specific T-cells that target CMV, adenovirus and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

    Patrick J. Hanley;Conrad Russell Young Cruz;Barbara Savoldo;Ann M. Leen

  • Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.

    Somala Mohammed;Sujita Sukumaran;Pradip Bajgain;Pradip Bajgain;Norihiro Watanabe

  • Improving T cell therapy for cancer.

    Ann M. Leen;Cliona M. Rooney;Aaron E. Foster

  • Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses

    Ann Leen;Pauline Meij;Irina Redchenko;Jaap Middeldorp

  • Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

    Ulrike Gerdemann;Jacqueline M Keirnan;Usha L Katari;Ryu Yanagisawa

  • Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

    Ulrike Gerdemann;Usha L Katari;Anastasia Papadopoulou;Jacqueline M Keirnan

  • How I treat adenovirus in hematopoietic stem cell transplant recipients

    Caroline A. Lindemans;Ann M. Leen;Jaap Jan Boelens

  • Fine-tuning the CAR spacer improves T-cell potency

    Norihiro Watanabe;Pradip Bajgain;Sujita Sukumaran;Salma Ansari

  • Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor

    Ann M Leen;Sujita Sukumaran;Norihiro Watanabe;Somala Mohammed

  • Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects.

    J. Joseph Melenhorst;Ann M. Leen;Catherine M. Bollard;Máire F. Quigley;Máire F. Quigley

  • Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.

    Ann M. Leen;Anne Christin;Mariam Khalil;Heidi Weiss

  • Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (g-rex)

    Juan F. Vera;Lara J. Brenner;Lara J. Brenner;Ulrike Gerdemann;Ulrike Gerdemann;Minhtran C. Ngo;Minhtran C. Ngo

  • Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.

    Xiaoou Zhou;Xiaoou Zhou;Antonio Di Stasi;Antonio Di Stasi;Siok Keen Tey;Siok Keen Tey;Robert A. Krance;Robert A. Krance

  • Adenovirus as an emerging pathogen in immunocompromised patients

    Ann M. Leen;Cliona M. Rooney

  • Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.

    Sari Pesonen;Iulia Diaconu;Lotta Kangasniemi;Tuuli Ranki

Frequent Co-Authors

Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine
Helen E. Heslop
Helen E. Heslop Baylor College of Medicine
Malcolm K. Brenner
Malcolm K. Brenner Baylor College of Medicine
Catherine M. Bollard
Catherine M. Bollard George Washington University
Adrian P. Gee
Adrian P. Gee Baylor College of Medicine
Stephen Gottschalk
Stephen Gottschalk St. Jude Children's Research Hospital
Gianpietro Dotti
Gianpietro Dotti University of North Carolina at Chapel Hill
Hao Liu
Hao Liu Indiana University
Barbara Savoldo
Barbara Savoldo University of North Carolina at Chapel Hill
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related online degrees such as nursing and psychiatric nurse practitioner programs can offer complementary career paths. Exploring the easiest nurse practitioner degree programs can provide a clear route for advancing clinical expertise with flexible learning options.

Specialized fields like mental health are also gaining momentum, and choosing from the best online psychiatric mental health nurse practitioner programs ensures strong clinical training essential for patient care. For students mindful of costs, the cheapest psych np programs online offer budget-friendly paths without sacrificing quality.

Career prospects for advanced nursing degrees are promising, with data showing competitive compensation. Understanding the doctor of nursing practice salary by state can help guide decisions about where to study and work, aligning education with future earning potential.

Best Scientists Citing Ann M. Leen

Trending Scientists

Recently Published Articles